Foghorn Therapeutics Inc. Share Price

Foghorn Therapeutics Inc. Share Price

NASDAQ: FHTX | Micro Cap
$1.83
+$0.04 (1.95%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Foghorn Therapeutics Inc. Stock Performance

Open
$1.82
Prev. Close
$1.79
Circuit Range
N/A
Day Range
$1.74 - $1.83
Year Range
$1.74 - $7.53
Volume
54,662
Average Traded
$1.77

Foghorn Therapeutics Inc. Share Price Today

As of 18 November 2026, Foghorn Therapeutics Inc.'s share price is $1.83. The stock opened at $1.82, compared to its previous close of $1.79. During today's trading session, Foghorn Therapeutics Inc.'s share price traded between $1.74 and $1.83, with an average price of $1.78. Over the past 52 weeks, the stock has recorded a high of $7.53 and a low of $1.74. In terms of performance, Foghorn Therapeutics Inc.'s share price has declined by 57.29% over the last six months and is down 61.15% on a year-on-year basis.

Foghorn Therapeutics Inc. Share Price Chart

Line chart of the Foghorn Therapeutics Inc. price trend over the selected period. The price rose overall, ranging from 1.74 to 1.83, ending at 1.83.
$1.74$1.83
L
Show Current Price
H

Foghorn Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$115.26M
PE Ratio (TTM)
11.39
Dividend Yield
0.00%
EPS (TTM)
$0.16
Revenue (TTM)
$30.91B
Return On Equity (TTM)
-66.88%
Profit Margin
-240.31%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
368.47%

Foghorn Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$9.25$3.27$16.07$83.54
Net Profit-$21.66-$19.88-$7.19$58.15
Net Profit Margin-234.16%-607.95%-44.74%69.61%
Income ChangeN/A8.22%63.83%908.76%

Foghorn Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$19.23$34.16$22.60$30.91
Net Profit-$108.88-$98.43-$86.62-$74.28
Net Profit Margin-566.20%-288.14%-383.27%-240.31%
Income ChangeN/A9.60%12.00%14.25%

About Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Foghorn Therapeutics Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.10
$1.81
-12.14%
Oct 2026
$1.98
$2.06
-42.30%
Sep 2026
$5.63
$3.57
-42.42%
Aug 2026
$4.56
$6.20
+36.41%
Jul 2026
$4.76
$4.54
-6.86%
Jun 2026
$4.31
$4.88
+13.89%
May 2026
$4.68
$4.29
-9.79%
Apr 2026
$4.97
$4.75
-0.63%
Mar 2026
$5.54
$4.78
-15.85%
Feb 2026
$5.91
$5.68
-1.05%
Jan 2026
$5.32
$5.74
+7.09%
Dec 2025
$4.66
$5.36
+13.80%

FHTX Share Price FAQs